Lantheus Alpha Therapy, LLC
SEC Form 4 insider trading activity
Lantheus Alpha Therapy, LLC has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 8, 2026.
On the most recent filing, Lantheus Alpha Therapy, LLC is listed as 10% Owner at Perspective Therapeutics, Inc. Inside the rolling window, Lantheus Alpha Therapy, LLC reported no open-market purchases and 5 open-market sales totaling $1.3M in CATX. The largest disclosed transaction in the window is a sale of 167,149 CATX shares on Sep 4, 2026, worth $526K.
Companies traded
Other insiders at CATX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.3M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lantheus Alpha Therapy, LLC made?
Lantheus Alpha Therapy, LLC has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Lantheus Alpha Therapy, LLC trade?
Lantheus Alpha Therapy, LLC has filed SEC Form 4 disclosures for 1 company, including CATX.
When was Lantheus Alpha Therapy, LLC's most recent SEC Form 4 filing?
Lantheus Alpha Therapy, LLC's most recent SEC Form 4 filing on Tracefour is dated Sep 8, 2026.
What is Lantheus Alpha Therapy, LLC's total buy and sell value in the current window?
Inside the rolling retention window, Lantheus Alpha Therapy, LLC bought $0 and sold $1.3M based on SEC Form 4 filings.
What was Lantheus Alpha Therapy, LLC's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 167,149 CATX shares on 2026-09-04, worth $526K, per SEC Form 4 filings.